<DOC>
	<DOCNO>NCT00906087</DOCNO>
	<brief_summary>The purpose study determine one gene cause glaucoma , call myocilin , associate large eye pressure blood pressure change sit lie position without glaucoma drug treatment glaucoma drug treatment combination medication call CosoptÂ® ( Merck &amp; Co. , Inc. ) .</brief_summary>
	<brief_title>Effect Myocilin Genetic Variants Intraocular Pressure Pressure Variation Sitting Supine Positions</brief_title>
	<detailed_description>Glaucoma important public health issue , identify new marker improve treatment outcomes high priority . Progress Mendelian genetic approach lead identify 15 gene 31 locus ( http : //www.ncbi.nlm.nih.gov/ ) ; however , since monogenic form glaucoma uncommon , approach need identify genetic marker contribute common risk factor , elevate IOP , IOP fluctuation , drug response variation . It well know IOP varies 24-hour period,1-6 mechanism regulate IOP rhythm yet fully know . Drance report 84 % normal eye ( N=320 eye ) IOP fluctuation less 5 mmHg contrast 6 % untreated glaucomatous eye ( N=138 ) .7 Drance clearly recognize IOP factor variable eye glaucoma . Attention IOP fluctuation glaucoma treatment important fluctuation lead progression . The variation IOP drug response profile measure select time 24-hour period relate mechanism action drug , endogenous circadian rhythm , glaucoma . We molecular genomic tool identify potential genetic marker variable trait . Advancing clinical research `` translational '' level important step integrate ever increase knowledge base genomics proteinomics clinical trial clinical study . Given infrastructure University Michigan strength glaucoma genetics resource clinic , well-positioned conduct translational research glaucoma . Although know myocilin ( MYOC ) mutation cause phenotype high pressure open-angle glaucoma ( OAG ) , effect MYOC mutation `` pre-symptomatic '' subject patient early OAG IOP variation know .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Early OAG , determine comprehensive ophthalmic examination Greater equal 18 year age Either gender Any race Both eye meet eligibility criterion Cup disc ratio le 0.8 determined fundoscopy confirm disc photo Visual field parameter study eye : Pattern Standard Deviation ( PSD ) great 1.0 dB less 6.0 dB Ability cooperate outpatient study involve least five visit four month study period Ability comply Cosopt treatment regimen Less equal 18 year old Refusal genotyped sign Informed Consent Protocol 1991144 Pregnant lactate woman Medical condition severe pulmonary compromise asthma emphysema cardiac contraindication betablockers Ocular disease chronic angleclosure glaucoma , iridocorneal endothelial disease , posterior polymorphous corneal dystrophy , epithelial downgrowth , uveitic glaucoma , neovascular glaucoma Ocular surgery glaucoma , include trabeculectomy , glaucoma filtration surgery , glaucoma drainage implant , laser cyclophotocoagulation Current use systemic steroid chemotherapeutic agent nonselectively inhibit divide cell Proliferative diabetic retinopathy , history panretinal photocoagulation treatment , diabetic macular edema , history macular grid laser treatment History change treatment involve use oral betablockers , angiotensin convert enzyme inhibitor , calcium channel blocker , oral alpha 2agonists prior two month next month ( i.e. , must stable treatment drug least two month ) Patients take erectile dysfunction drug ( i.e. , Viagra , Cialis , Levitra ) Contradictions : bronchial asthma history bronchial asthma severe chronic obstructive pulmonary disease sinus bradycardia second third degree atrioventricular block overt cardiac failure cardiogenic shock hypersensitivity component Cosopt</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Myocilin gene</keyword>
	<keyword>Glaucoma</keyword>
	<keyword>dorzolamide timolol combination eyedrop</keyword>
</DOC>